Bengaluru: AstraZeneca Pharma India Limited has received a demand notice from the National Pharmaceutical Pricing Authority (NPPA) for alleged overcharging under the Drugs (Prices Control) Order (DPCO), 2013. The company stated that it is currently reviewing the demand notice and will take appropriate steps in accordance with applicable law. The notice relates to an alleged violation of the provisions of the DPCO, 2013. According to the details shared by the company, the NPPA has issued a demand notice for Rs. The company stated that it is reviewing the demand notice and will take appropriate legal steps in accordance with applicable law.